|
Video: What is a Stock Split?
|
|
Tobira Therapeutics is a clinical-stage biopharmaceutical company focused on the development and commercialization of therapies to treat liver disease, inflammation, fibrosis and human immunodeficiency virus (HIV). Co.'s product candidate, cenicriviroc (CVC), is an immunomodulator and dual inhibitor of CCR2 and CCR5 being evaluated for the treatment of non-alcoholic steatohepatitis (NASH), primary sclerosing cholangitis (PSC), and as an adjunctive therapy to standard of care in HIV. Co. operates in one reportable segment in the U.S. of America. CVC is an oral, once-daily, potent immunomodulator with a binding affinity. NASH is a severe type of non-alcoholic fatty liver disease. According to our TBRA split history records, TBRA has had 1 split. | |
|
TBRA (TBRA) has 1 split in our TBRA split history database. The split for TBRA took place on May 05, 2015. This was a 1 for 9 reverse split, meaning for each 9 shares of TBRA owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 111.111111111111 share position following the split.
When a company such as TBRA conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the TBRA split history from start to finish, an original position size of 1000 shares would have turned into 111.111111111111 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into TBRA shares, starting with a $10,000 purchase of TBRA, presented on a split-history-adjusted basis factoring in the complete TBRA split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/01/2014 |
|
End date: |
11/01/2016 |
|
Start price/share: |
$114.84 |
|
End price/share: |
$42.09 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-63.35% |
|
Average Annual Total Return: |
-32.14% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$3,664.72 |
|
Years: |
2.59 |
|
|
|
Date |
Ratio |
05/05/2015 | 1 for 9 |
|
|